Sphingolipid biosynthesis modulates plasmodesmal ultrastructure and phloem unloading by Yan, Dawei et al.
Articles
https://doi.org/10.1038/s41477-019-0429-5
Sphingolipid biosynthesis modulates 
plasmodesmal ultrastructure and phloem 
unloading
Dawei Yan   1,13, Shri Ram Yadav2,3,13, Andrea Paterlini   1, William J. Nicolas4,12, Jules D. Petit4, 
Lysiane Brocard5, Ilya Belevich   2, Magali S. Grison4, Anne Vaten2, Leila Karami2,6, Sedeer el-Showk2, 
Jung-Youn Lee7, Gosia M. Murawska8,9, Jenny Mortimer   8,9, Michael Knoblauch10, Eija Jokitalo2, 
Jonathan E. Markham11, Emmanuelle M. Bayer   4* and Ykä Helariutta   1,2*
1The Sainsbury Laboratory, University of Cambridge, Cambridge, UK. 2Helsinki Institute of Life Science/Institute of Biotechnology, University of Helsinki, 
Helsinki, Finland. 3Department of Biotechnology, Indian Institute of Technology, Roorkee, India. 4Laboratoire de Biogenèse Membranaire, UMR 5200, 
CNRS, Université de Bordeaux, Villenave d’Ornon, France. 5Bordeaux Imaging Centre, Plant Imaging Platform, UMS 3420, INRA-CNRS-INSERM, University 
of Bordeaux, Villenave-d’Ornon, France. 6Department of Horticulture, Faculty of Agriculture and Natural Resources, Persian Gulf University, Bushehr, Iran. 
7Department of Plant and Soil Sciences, Delaware Biotechnology Institute, University of Delaware, Newark, DE, USA. 8Biosciences Area, Lawrence Berkeley 
National Laboratory, Berkeley, CA, USA. 9Joint Bioenergy Institute, Emeryville, CA, USA. 10School of Biological Sciences, Washington State University, 
Pullman, WA, USA. 11Department of Biochemistry, University of Nebraska-Lincoln, Lincoln, NE, USA. 12Present address: Division of Biology and Biological 
Engineering, California Institute of Technology, Pasadena, CA, USA. 13These authors contributed equally: Dawei Yan, Shri Ram Yadav.  
*e-mail: emmanuelle.bayer@u-bordeaux.fr; yrjo.helariutta@slcu.cam.ac.uk
SUPPLEMENTARY INFORMATION
In the format provided by the authors and unedited.
















































































Supplementary Fig. 1. plm-2 rescues cals3-3d in Col-0 background, as 
well as plm-1 in C24 background. a. Seedling phenotype of wild-type C24, 
cals3-1d, plm-1;cals3-1d and plm-1;cals3-1d transformed with PLM genomic 
insert. The experiment was repeated independently three times with similar 
results.b. Seedling phenotype of wild-type Col-0, cals3-3d, plm-2;cals3-3d
and plm-2;cals3-2d transformed with PLM genomic and YFP-fusion inserts. 
c. pSUC2::GFP in the roots of wild-type Col-0, cals3-3d, plm-2;cals3-3d and 
plm-2;cals3-2d transformed with PLM genomic and YFP-fusion inserts. All 
the experiments were repeated independently three times with similar 

























Supplementary Fig. 2. Root elongation and plant biomass assays. a. 
Root elongation in every single day of Col-0 and plm-2. The numbers of 
biologically independent plants are indicated in the graph. b. Germination 
rate of Col-0 and plm-2 seeds. Data are based on 3 independent 
biological replicates with total160 seeds. c. Adult plants of C24 and plm-
1. This experiment was repeated independently three times with similar 
results. The linear model was use for test. d. Adult plants of Col-0 and 
plm-2. This experiment was repeated independently three times with 
similar results. e. Root (left panel) and shoot (right panel) biomass of 
adult plants at terminal flowering stage. n = 29 (both Col-0 and plm-2 ) 
biologically independent plants. f. GFP intensity in the root tip of 3-day-
old seedlings. n = 14 (Col-0), n = 13 (plm-2) biologically independent 
plants. In the box plots, the boxes indicate the first and third quartiles and 
the whiskers indicate the minimum and maximum values. The black lines 
within the boxes indicate the median values. Outliers are shown as dots. 
Significant differences were determined by two-tailed Mann-Whitney-
















































n= 205  207      203  206      200  200      186  181      168  165      158  160
ol-0 plm-2
Col-0 plm-2
P = 1.52 x 10 -14
P = 8.15 x 10 -9
P = 0.0014





Supplementary Fig. 3. Protein Sequence alignment of PLM (At1g43580) and HsSMSs.
Four conserved domains (D1, D2, D3 and D4) within human SMSs are highlighted with black 
lines. H-H-D residues that form a catalytic triad are highlighted by blue arrows.  * , identical 





Supplementary Fig. 4. Protein Sequence alignment of PLM (At1g43580) and AtIPCSs. *
identical residues. · similar residues.
Leaf
Hypocotyl
Supplementary Fig 5.  Subcellular localization of PLM-YFP.  a. Co-localization of PLM-
YFP with RFPer (RFP-HDEL) in leaf epidermal cells. b. Co-localization of PLM-YFP with 
RFPer in hypocotyl epidermal cells. c. Transient co-expression of PLM-YFP with RTNLB6-
RFP in the leaf cells of Nicotiana benthamiana. All the experiments were repeated 
independently three times with similar results.
pPLM::PLM-YFP  pG1090::RFPer Merged


































































Ceramides Col-0 d18:0 plm-2 d18:0
Col-0 d18:1 plm-2 d18:1
Col-0 t18:0 plm-2 t18:0
Col-0 t18:1 plm-2 t18:1




























Supplementary Fig.6. Repetition of LCB(P)s and complex sphingolipid species analysis in 
wild-type Col-0 and plm-2. Measurements are the average of five replicates (n = 5 independent 
samples). Data are means ± SD. Statistically significant differences are indicated by two-tailed 








































































Supplementary Fig. 7. GIPC glycosylation assay. a. Thin layer chromatography (TLC) of an enriched 
GIPC fraction from 5-day-old roots stained with primuline (binding to certain lipid classes) and orcinol
(revealing sugars). b. Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) 
analysis of GIPC enriched fraction from 5-day-old roots to identify highly glycosylated GIPCs. All the 
experiments were repeated independently two times with similar results.
a b






Supplementary Fig. 8. Plant routine lipids profile. a.Plant polar lipids assay in 
wild-type Col-0 and plm-2. Data are means ± SD and based on five replicates (n = 
5 independent samples). b. Relative amount of DAG in wild-type Col-0 and plm-2. 
Data are means ± SD and based on five replicates with independent samples. c. 
The total sterol amount in 5-day-old seedlings of wild-type and plm mutants. Data 
are based on three replicates with independent samples. The boxes indicate the 
first and third quartiles and the whiskers indicate the minimum and maximum 
values. The black lines within the boxes indicate the median values. Significant 
differences were determined by two-tailed Mann-Whitney-Wilcoxon test. No 

































































































































































Ceramides Col-0 d18:0 ipcs2 d18:0
Col-0 d18:1 ipcs2 d18:1
Col-0 t18:0 ipcs2 t18:0
Col-0 t18:1 ipcs2 t18:1
Supplementary Fig.9 Analysis of LCB(P)s and complex sphingolipid species in wild-type Col-0 and  ipcs2 
(SALK_206784). Measurements are the average of five replicates (n = 5 independent samples). Data are means ±
SD. Statistically significant differences are indicated by two-tailed Student’s t-test. *, P<0.05. ** P <0.01.










































































Supplementary Fig.10. PLM promotes GFP unloading without 
affecting GFP and SUC2 expression. a. Col-0 and plm-2 carrying 
inducible pSUC2-XVE::GFP upon 25h induction by 5 µm β-
estradiol. An area of 50 x 40 µm2 , 50 µm from QC, was used for 
fluorescence intensity quantification. n = 15 (Col-0), n = 13 (plm-2) 
biologically independent plants. The boxes indicate the first and 
third quartiles and the whiskers indicate the minimum and 
maximum values. The black lines within the boxes indicate the 
median values. b. qRT-PCR for GFP and SUC2 transcript levels in 
wild-type Col-0 and plm-2. Data are based on three independent 
experiments. Data are means ± SD. Significant differences were 
determined by two-tailed Mann-Whitney-Wilcoxon test (a) and two-
sided student’s t-test (b). * P<0.05. n.s., no significance. Scale 
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Supplementary Fig. 11. Unloading pattern of GFP fusion 
proteins with larger size in roots. a. pSUC2::SPORAMIN-GFP 
and pSEOR::SEOR-YFP in Col-0 and plm-2. b. Grafting assay using 
pSUC2::SPORAMIN-GFP27 and pSEOR::SEOR-YFP26 shoots as 
scions and Col-0 and plm-2 roots as stocks. Scale bars, 50 µm (a,b). 






















Col-0     plm-2 
pAPL::YFPer
Supplementary Fig. 12. Root phloem development is not 
impaired by plm mutation. a. pAPL::YFPer in wild-type Col-0 and 
plm-2. The experiment was repeated four times independently with 
similar results. b. pCALS7::H2B-YFP51 and the distances from QC 
to the first enucleated cell in wild-type Col-0 (n = 9) and plm-2 (n = 
14) independent plants. c. pCALS8:: YFPer and the distances from 
QC to the first expressed cell in wild-type Col-0 (n = 29) and plm-2 
(n = 25) independent plants. Data represent means ± SD.  
Significant differences were determined by two-tailed student’s t 
test. Scale bars, 50 µm (a,b,c).
a b
c
Col-0      plm-2 
Col-0     plm-2 
P = 0.27
P = 0.089
n.s.   















































































































































Supplementary Fig 13. FRAP assays in C24 and plm-1 expressing pSUC2::GFP. a. GFP movement
from PPP to endodermis post bleaching of outward layers in the unloading domain. n= 9 (C24) and 7 (plm-
1) biologically independent samples. b. GFP movement from SE to PPP post bleaching of outward layers in
the unloading domain. n= 7 (C24) and 7 (plm-1) independent plants. Data represent means ± SD.
a
b





Supplementary Fig. 14. Roots with FBI treatment phenocopies plm in 
enhanced GFP unloading. a. Fluorescence intensity in the root meristem 
of wild-type Col-0 upon 72h treatment by different concentration of FB1. 3-
day-old seedlings growing on normal media were used for treatment. An 
area of 50 x 40 µm2, 50 µm from QC, was transferred for quantification. n = 
16 (0 µM), n = 14 (0.1 µM), n = 14 (0.3 µM),  n = 16 (0.5 µM) independent 
plants. b. Root growth of wild-type Col-0 upon 72h treatment by different 
concentration of FB1. 3-day-old seedlings growing on normal media were 
transferred for treatment. n = 10 independent plants for each concentration. 
The boxes indicate the first and third quartiles and the whiskers indicate the 
minimum and maximum values. The black lines within the boxes indicate 
the median values. Outliers are shown as dots. Significant differences were 











Col-0                                 plm-2
No primary antibody       No secondary antibody 
Col-0       plm-2 Col-0                        cals3-3d               plm-2; cals3-3d
a b
c d
Supplementary Fig. 15. Callose deposition analysis. a. Callose deposition (green) in different cell layers shown 
by immunolocalization using callose antibody. b. Immunolocalization controls without primary and secondary 
antibody. c. Aniline blue stained primary roots of wild-type Col-0 and plm-2. d. Aniline blue stained lateral roots of 
wild-type Col-0, cals3-3d and cals3-3d;plm-2. All the experiments were repeated independently three times with 













































Supplementary Fig. 16. Root growth assay by alloxan treatment. 5-day-old seedlings were transferred 
to same media added with 0, 1, 1.5mM alloxan and the root elongation at 28, 52 and 65h was measured. . 
b. Callose accumulation in roots by aniline blue staining at 28h after transferred to media with 0 and 1.5 
mM alloxan. The experiment is repeated three times independently with similar results.  A 138 x 60 µm 
area in the central part starting from transition zone was used for intensity quantification. The boxes 
indicate the first and third quartiles and the whiskers indicate the minimum and maximum values. The black 
lines within the boxes indicate the median values. Outliers are shown as dots. Independent plant numbers 
(n) are indicated in the graphs. Significant differences between Col-0 and plm-2 under same conditions 
were determined by two-tailed Mann-Whitney-Wilcoxon test. ** P<0.01. ** P<0.01. n.s., no significance. 
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P = 1.16 x 10 -6






z = 15 nm





Supplementary Fig. 17. plm-2 still possesses type II plasmodesmata at the SE-PPP interface of the unloading zone.
Examples of type II plasmodesmata in plm-2 roots detected with electron tomography at the SE-PPP interface, within the unloading domain. Due 
to the large size of these PDs the full volume was not contained within the section. Reconstructions are therefore partial with missing volumes. P-
lasmodesmata are not classified by morphology due to missing volumes that would make the calls arbitrary. In general, they were branched in n-
ature. Panels with black background are 3D reconstructions based on 2D image stacks. Plasma membrane (PM) is rendered in yellow, desm-
otubule (DT) and ER in light blue, tethers within plasmodesmata in red. Selected 2D views are displayed in the neighbouring panels with zoom-
s for tethers within type II plasmodesmata (with a model overlay). Distance to the first 2D view is indicated under or above each panel. Arrows, s-
ymbols and labels indicate various plasmodesmata components and follow the colour scheme of the 3D models (*  tether elements within plasmo-
desmata). Scale bars are of 50nm or 25nm for the zoomed images. Experiment was repeated two times independently with similar results.                                .  
z = 9 nm (zoom)
z = 0 nm




z = 15 nm (zoom)
*
*
Supplementary Table 1. Primer used in this study.






























PLM-g-attB1 GGGGACAAGTTTGTACAAAAAAGCAGGCTCCATGACTAAAGGTGGACTTGG PLM genomic 
sequence
PLM-g-attB2 GGGGACCACTTTGTACAAGAAAGCTGGGTCGCCGTCGCTTGTCAAAGTCA








F, forward. R, reversed.
















































































































































































































Supplementary Table 3. P values (t-test) of sphingolipid profile analysis. n.d.,no data.
Fig. 3c. C24 and plm-1 .
Ceramides 16:0 18:0 20:0 20:1 22:0 22:1 23:0 23:1 24:0 24:1 25:0 25:1 26:0 26:1
d18:0 6.85E-01 n.d. n.d. n.d. 3.95E-02 n.d. n.d. n.d. 1.39E-01 4.00E-03 1.48E-01 n.d. 3.60E-02 n.d.
d18:1 8.57E-01 7.06E-01 n.d. n.d. n.d. 7.22E-01 n.d. n.d. 1.30E-02 4.60E-01 n.d. n.d. n.d. n.d.
t18:0 9.81E-01 7.67E-01 3.71E-01 n.d. 3.00E-02 8.74E-01 5.71E-02 8.07E-01 2.04E-03 5.34E-04 3.90E-02 1.34E-02 1.26E-03 2.42E-04
t18:1 3.19E-01 5.84E-01 1.07E-01 n.d. 8.76E-04 4.45E-01 1.27E-02 8.24E-01 7.10E-05 2.23E-05 3.06E-03 6.84E-03 1.58E-03 2.74E-04
Hydroxyceramides 16:0 18:0 20:0 20:1 22:0 22:1 23:0 23:1 24:0 24:1 25:0 25:1 26:0 26:1
d18:0 1.55E-01 n.d. n.d. n.d. 6.68E-01 n.d. n.d. n.d. 9.83E-01 3.23E-01 n.d. n.d. 1.56E-01 n.d.
d18:1 3.49E-03 n.d. n.d. n.d. n.d. n.d. n.d. n.d. 1.74E-01 4.53E-01 n.d. n.d. n.d. n.d.
t18:0 8.51E-01 9.27E-01 4.20E-01 n.d. 8.02E-01 1.51E-01 3.94E-01 5.66E-01 6.60E-01 7.63E-01 9.17E-01 2.46E-01 8.79E-01 5.29E-01
t18:1 2.01E-01 2.54E-01 6.89E-01 n.d. 5.79E-02 2.61E-03 6.24E-02 1.95E-02 5.01E-02 1.36E-01 1.62E-02 1.43E-01 5.87E-02 2.49E-01
GIPCs 16:0 18:0 20:0 20:1 22:0 22:1 23:0 23:1 24:0 24:1 25:0 25:1 26:0 26:1
d18:0 8.75E-01 2.11E-01 1.62E-01 n.d. 6.45E-01 n.d. 2.45E-01 n.d. 9.35E-01 9.73E-01 n.d. n.d. 5.83E-01 7.48E-01
d18:1 2.35E-02 6.49E-01 9.04E-01 n.d. 4.45E-02 n.d. n.d. n.d. 1.91E-02 8.27E-04 4.65E-01 9.64E-01 2.58E-01 2.44E-01
t18:0 6.54E-01 8.69E-02 1.62E-01 1.03E-01 9.24E-01 9.77E-01 4.47E-01 3.25E-01 7.74E-01 5.25E-01 7.46E-01 3.92E-01 6.87E-01 9.61E-01
t18:1 2.27E-02 3.22E-01 1.31E-01 1.40E-02 1.22E-02 1.21E-02 5.82E-02 4.37E-02 2.67E-02 9.07E-02 1.95E-01 4.53E-02 2.94E-01 2.52E-01
Glucosylceramides 16:0 18:0 20:0 20:1 22:0 22:1 23:0 23:1 24:0 24:1 25:0 25:1 26:0 26:1
d18:0 6.65E-01 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
d18:1 3.11E-03 3.72E-01 6.55E-01 n.d. 6.09E-02 n.d. n.d. n.d. 3.38E-02 9.85E-02 n.d. n.d. 2.17E-01 7.43E-02
t18:0 7.24E-01 n.d. n.d. n.d. 5.21E-01 n.d. 5.63E-01 n.d. 6.45E-01 2.50E-01 n.d. n.d. 7.45E-01 8.14E-01
t18:1 1.34E-02 5.85E-01 6.77E-02 n.d. 2.32E-02 3.69E-03 5.07E-02 1.35E-02 1.04E-02 1.88E-03 1.66E-01 2.10E-02 1.08E-01 3.63E-01
Fig. 3d. Col-0 and plm-2 .
Ceramides 16:0 18:0 20:0 20:1 22:0 22:1 23:0 23:1 24:0 24:1 25:0 25:1 26:0 26:1
d18:0 2.51E-01 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
d18:1 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 1.21E-01 n.d. n.d. n.d. n.d.
t18:0 5.37E-01 n.d. 1.15E-01 n.d. 6.58E-02 n.d. 2.67E-03 1.92E-01 1.46E-04 2.90E-04 8.37E-03 9.70E-03 1.70E-04 2.89E-04
t18:1 4.70E-01 n.d. 7.22E-01 n.d. 7.71E-03 3.78E-02 1.30E-04 2.49E-02 4.09E-06 9.32E-07 3.80E-04 6.07E-03 3.50E-06 5.44E-05
Hydroxyceramides 16:0 18:0 20:0 20:1 22:0 22:1 23:0 23:1 24:0 24:1 25:0 25:1 26:0 26:1
d18:0 7.16E-01 n.d. n.d. n.d. 7.74E-03 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
d18:1 5.06E-01 n.d. n.d. n.d. n.d. n.d. n.d. n.d. 9.58E-01 6.32E-01 n.d. n.d. n.d. n.d.
t18:0 1.96E-01 n.d. 1.87E-01 n.d. 4.28E-02 5.20E-02 n.d. 6.50E-01 9.37E-02 5.72E-02 9.04E-02 3.59E-01 1.36E-01 8.40E-01
t18:1 1.48E-02 4.16E-03 1.18E-02 n.d. 2.08E-02 n.d. 5.38E-02 1.73E-02 3.51E-02 1.28E-02 6.29E-02 2.89E-02 4.51E-02 1.02E-01
GIPCs 16:0 18:0 20:0 20:1 22:0 22:1 23:0 23:1 24:0 24:1 25:0 25:1 26:0 26:1
d18:0 9.69E-02 2.65E-01 n.d. n.d. 1.01E-02 n.d. 6.78E-01 8.72E-01 3.32E-03 4.89E-03 n.d. n.d. 5.82E-01 4.73E-02
d18:1 3.07E-01 5.53E-01 n.d. n.d. 5.70E-02 1.30E-01 n.d. n.d. 3.27E-03 9.70E-01 n.d. n.d. 2.73E-04 7.80E-04
t18:0 7.12E-02 2.38E-02 1.86E-02 9.72E-02 1.97E-02 1.77E-02 9.30E-03 3.87E-02 2.31E-03 1.92E-03 5.05E-03 2.86E-02 3.18E-05 2.00E-04
t18:1 2.82E-02 3.53E-02 8.86E-02 2.18E-01 3.08E-02 5.16E-01 1.08E-02 4.99E-02 3.81E-03 8.59E-03 7.30E-04 1.66E-03 3.21E-02 2.29E-03
Glucosylceramides 16:0 18:0 20:0 20:1 22:0 22:1 23:0 23:1 24:0 24:1 25:0 25:1 26:0 26:1
d18:0 6.39E-01 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
d18:1 2.83E-01 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
t18:0 1.32E-01 n.d. n.d. n.d. 5.78E-03 n.d. n.d. n.d. 3.48E-01 4.98E-01 n.d. n.d. n.d. n.d.
t18:1 7.62E-01 4.63E-02 2.41E-02 n.d. 2.80E-01 7.20E-04 6.96E-02 n.d. 2.20E-02 2.42E-01 5.02E-01 1.37E-01 6.03E-02 8.71E-01
Fig. S6. Col-0 and plm-2 .
Ceramides 16:0 18:0 20:0 20:1 22:0 22:1 23:0 23:1 24:0 24:1 25:0 25:1 26:0 26:1
d18:0 5.91E-01 n.d. n.d. n.d. 1.94E-01 n.d. 7.58E-01 n.d. 5.16E-01 5.78E-01 5.53E-01 n.d. 5.17E-01 n.d.
d18:1 1.17E-01 5.27E-01 n.d. n.d. n.d. 6.33E-01 n.d. n.d. 1.09E-01 3.69E-02 n.d. n.d. 1.36E-01 n.d.
t18:0 1.67E-01 2.15E-01 6.72E-01 n.d. 2.17E-02 7.71E-01 3.15E-03 1.22E-01 1.95E-04 3.64E-04 5.97E-04 1.30E-04 9.20E-04 1.18E-04
t18:1 2.66E-01 1.23E-01 2.47E-01 6.99E-01 6.61E-02 3.23E-01 1.33E-03 9.20E-01 3.59E-03 1.60E-03 4.24E-04 8.44E-04 4.71E-04 2.55E-04
Hydroxyceramides 16:0 18:0 20:0 20:1 22:0 22:1 23:0 23:1 24:0 24:1 25:0 25:1 26:0 26:1
d18:0 6.28E-03 n.d. n.d. n.d. 7.41E-01 n.d. n.d. n.d. 9.48E-01 4.55E-02 n.d. n.d. 7.33E-01 n.d.
d18:1 6.15E-02 n.d. n.d. n.d. n.d. n.d. n.d. n.d. 7.22E-01 3.87E-01 n.d. n.d. n.d. n.d.
t18:0 5.43E-01 7.73E-02 1.96E-01 n.d. 6.39E-01 4.61E-01 5.56E-01 5.94E-01 8.85E-01 5.04E-02 4.35E-02 9.40E-02 3.47E-01 3.82E-02
t18:1 9.08E-01 5.81E-01 8.41E-01 6.90E-01 9.33E-01 7.39E-01 6.17E-01 6.82E-01 7.91E-01 5.20E-02 7.21E-01 3.17E-01 3.89E-01 9.67E-02
GIPCs 16:0 18:0 20:0 20:1 22:0 22:1 23:0 23:1 24:0 24:1 25:0 25:1 26:0 26:1
d18:0 5.25E-01 1.15E-01 3.81E-01 n.d. 4.34E-01 n.d. 3.90E-01 n.d. 2.43E-01 3.19E-02 5.51E-01 n.d. 3.04E-01 4.23E-02
d18:1 5.73E-01 4.09E-01 5.00E-01 n.d. 9.25E-01 n.d. n.d. n.d. 6.21E-02 5.14E-03 n.d. 2.70E-01 2.52E-01 1.37E-01
t18:0 3.69E-01 6.62E-01 6.25E-01 4.71E-03 8.98E-01 7.09E-01 8.14E-01 9.42E-01 4.53E-01 3.62E-01 7.21E-01 8.13E-01 4.39E-01 7.12E-01
t18:1 8.46E-01 8.75E-02 2.05E-01 5.41E-03 8.21E-01 1.32E-01 5.58E-01 1.25E-01 3.30E-01 1.66E-01 3.11E-01 2.38E-01 3.36E-01 2.13E-01
Glucosylceramides 16:0 18:0 20:0 20:1 22:0 22:1 23:0 23:1 24:0 24:1 25:0 25:1 26:0 26:1
d18:0 1.07E-01 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
d18:1 3.50E-01 6.41E-01 9.60E-01 n.d. 1.38E-01 n.d. n.d. n.d. 3.10E-01 4.54E-01 n.d. n.d. 2.68E-01 7.09E-02
t18:0 7.04E-02 n.d. n.d. n.d. 9.46E-02 8.38E-02 n.d. n.d. 2.28E-01 1.84E-01 n.d. n.d. 2.05E-01 9.67E-01
t18:1 2.36E-01 2.24E-01 7.28E-02 n.d. 1.63E-01 1.03E-01 1.69E-01 1.46E-01 2.80E-01 4.53E-01 2.99E-01 2.23E-01 1.01E-01 5.01E-01
Fig. S9. Col-0 and ipcs2 .
Ceramides 16:0 18:0 20:0 20:1 22:0 22:1 23:0 23:1 24:0 24:1 25:0 25:1 26:0 26:1
d18:0 6.79E-01 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
d18:1 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 8.72E-02 n.d. n.d. n.d. n.d.
t18:0 5.04E-01 n.d. 7.60E-01 n.d. 3.23E-01 n.d. 2.98E-01 4.57E-01 8.15E-02 8.61E-02 4.10E-01 9.42E-01 4.94E-02 4.90E-02
t18:1 2.72E-01 n.d. 2.08E-01 n.d. 3.08E-01 2.33E-01 9.32E-01 9.28E-01 9.43E-02 9.94E-02 1.41E-01 6.44E-02 2.21E-02 9.31E-02
Hydroxyceramides 16:0 18:0 20:0 20:1 22:0 22:1 23:0 23:1 24:0 24:1 25:0 25:1 26:0 26:1
d18:0 1.35E-02 n.d. n.d. n.d. 5.32E-02 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
d18:1 2.03E-01 n.d. n.d. n.d. n.d. n.d. n.d. n.d. 4.45E-01 7.86E-01 n.d. n.d. n.d. n.d.
t18:0 4.97E-02 n.d. 1.52E-01 n.d. 9.47E-02 2.09E-02 n.d. 6.02E-01 1.28E-01 9.81E-03 2.07E-01 3.64E-01 1.29E-01 6.22E-02
t18:1 1.26E-01 6.88E-02 1.40E-01 n.d. 6.28E-02 n.d. 1.53E-01 6.51E-02 7.90E-02 3.67E-03 6.06E-02 5.36E-02 1.21E-01 3.42E-03
GIPCs 16:0 18:0 20:0 20:1 22:0 22:1 23:0 23:1 24:0 24:1 25:0 25:1 26:0 26:1
d18:0 1.10E-01 9.71E-02 n.d. n.d. 2.99E-01 2.33E-01 9.33E-01 1.76E-01 9.88E-01 5.75E-01 n.d. n.d. 1.69E-01 2.84E-01
d18:1 1.18E-01 7.55E-01 n.d. n.d. 3.86E-01 1.68E-02 n.d. n.d. 7.34E-01 6.83E-02 n.d. n.d. 1.17E-01 2.93E-01
t18:0 3.64E-01 3.89E-01 2.39E-03 4.07E-01 2.91E-01 1.91E-01 4.09E-01 3.39E-01 8.72E-01 1.98E-01 6.37E-01 4.92E-01 2.60E-01 9.52E-01
t18:1 7.66E-02 1.56E-01 1.49E-01 5.82E-01 8.49E-02 1.30E-01 5.64E-01 1.48E-01 4.18E-02 5.26E-01 1.86E-01 1.79E-01 9.61E-02 5.28E-01
Glucosylceramides 16:0 18:0 20:0 20:1 22:0 22:1 23:0 23:1 24:0 24:1 25:0 25:1 26:0 26:1
d18:0 4.48E-01 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
d18:1 4.79E-01 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
t18:0 9.65E-01 n.d. n.d. n.d. 8.31E-01 n.d. n.d. n.d. 8.05E-01 6.09E-01 n.d. n.d. n.d. n.d.
t18:1 1.70E-01 2.65E-01 2.12E-01 n.d. 4.05E-01 9.00E-01 7.17E-01 n.d. 6.30E-01 4.47E-01 8.33E-01 4.97E-01 4.98E-01 1.66E-01
